LeMaitre Vascular Inc (LMAT)

Return on equity (ROE)

		Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020	Dec 31, 2019	Sep 30, 2019	Jun 30, 2019	Mar 31, 2019
Net income (ttm)	US$ in thousands	30,105	27,267	25,221	20,638	20,636	21,184	22,232	27,016	26,907	27,765	28,774	23,975	21,220	18,800	16,471	17,595	17,934	19,346	18,476	22,603
Total stockholders’ equity	US$ in thousands	297,900	288,637	283,827	274,165	268,201	261,247	258,033	257,787	254,151	249,048	185,833	177,525	172,572	160,983	152,629	148,835	148,141	142,316	137,537	133,088
ROE		10.11%	9.45%	8.89%	7.53%	7.69%	8.11%	8.62%	10.48%	10.59%	11.15%	15.48%	13.51%	12.30%	11.68%	10.79%	11.82%	12.11%	13.59%	13.43%	16.98%

December 31, 2023 calculation

ROE = Net income (ttm) ÷ Total stockholders’ equity
= $30,105K ÷ $297,900K
= 10.11%

ROE, or return on equity, is a key financial ratio that measures a company's ability to generate profits from its shareholder's equity. Lemaitre Vascular Inc's ROE over the past 8 quarters has shown some fluctuations.

In Q4 2023, the ROE was 10.11%, which indicates that the company generated a return of 10.11% on its shareholders' equity during that period. This was a slight improvement from the previous quarter's ROE of 9.45% in Q3 2023. However, the ROE in Q4 2023 was lower compared to the same period in the prior year, where it stood at 7.69% in Q4 2022.

Overall, Lemaitre Vascular Inc has maintained relatively stable ROE figures ranging from 7.53% to 10.48% over the past 8 quarters. This suggests that the company has been efficient in utilizing its shareholder's equity to generate profits, although there have been some fluctuations in performance. Further analysis of the company's financial statements and operations would provide greater insight into the factors affecting its ROE.